Cardiovascular Disease (CVD) and Metabolic Health

Research reveals that chronic inflammation plays a pivotal role in the development of cardiovascular disease (CVD). Clinically, prolonged inflammation in CVD is associated with factors such as unresolved infections, low physical activity, visceral obesity, dysbiosis, poor diet, stress, disturbed sleep, and pollutant exposure. Natural Medicine Practitioners are well-equipped to support patient recovery.

CVD affects the overall health and function of the heart and blood vessels. Prolonged inflammation in these tissues can lead to heightened immune activation and oxidative stress, resulting in vascular plaque build-up, which increases the risk of stroke and myocardial infarction (heart attacks).

These vascular changes are often compounded by metabolic dysfunction. Observed in 20% to 25% of patients worldwide, abnormally elevated blood lipids, insulin, and glucose significantly increase CVD risk.

Conventional care addresses the signs and symptoms of CVD, such as hypertension, dyslipidemia, hyperinsulinemia, and hyperglycemia. While this approach is necessary, addressing the underlying inflammatory drivers is crucial for achieving the best results.

Key Treatment Aspects for CVD and Metabolic Dysfunction

1. Core Prescription

CVD Patients: Bioavailable magnesium, high-strength pure fish oil, and enhanced absorption coenzyme Q10.

Metabolic Dysfunction Patients: A highly bioavailable magnesium formula combined with a comprehensive metabolic-balancing formula. These therapeutic tools address underlying pathology and support cardiovascular and metabolic health while more specific requirements are determined.

2. Assess Patient Status

Take a thorough patient history, including diet and lifestyle.

Review pathology results.

Utilize simple in-clinic testing, such as blood pressure and omega-3 index assessment, to build a complete picture and determine treatment goals and priorities.

3. Patient-Specific Prescribing

Symptomatic Relief: Provide support specific to each patient’s symptoms, including high blood pressure, elevated blood sugars, cholesterol, and triglycerides. Improvement in these areas will motivate patients to continue making positive changes.

Target Drivers: Support patients in managing contributing factors associated with CVD and metabolic dysfunction, such as obesity, poor diet, and unhealthy lifestyle. Help patients modify their habits and provide tools for making healthier choices. Additional treatment may be required for infection, toxicity, and stress.

Programs like the Metagenics Shake It Practitioner Weight Management Program, Clinical Detoxification Program, and the Clinically Effective Stress, Anxiety, and Mood Range offer structured approaches to support these areas.